Regeneration of tissues and organs is now within the technological reach of modern medicine. With such advancements, substantial improvements to existing standards-of-care are very real possibilities. This review will focus on regenerative medicine approaches to treating specific maladies of the bladder and kidney, including the biological basis of regeneration and the history of regenerative medicine in the urinary system. Current clinical management approaches will be presented within the context of future directions including cell-based regenerative therapies.
Get full access to this article
View all access options for this article.
References
1.
LysaghtM.J., VoneshE.F., GotchF., IbelsL., KeenM., LindholmB., NolphK.D., PollockC.A., ProwantB., FarrellP.C.The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans, 37:598. 1991.
2.
OberbauerR., KreisH., JohnsonR.W., MotaA., ClaessonK., RuizJ.C., WilczekH., JamiesonN., HenriquesA.C., PaczekL., ChapmanJ., BurkeJ.T.Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study. Transplantation, 76:364. 2003.
3.
KhouryJ.M., TimmonsS.L., CorbelL., WebsterG.D.Complications of enterocystoplasty. Urology, 40:9. 1992.
4.
BasuJ., LudlowJ.W.Tissue engineering of solid and tubular organs—an industry perspective. Winslet-GendebienS.Advances in Regenerative Medicine. Rijeka, Croatia: InTech Publishing, 2011; 235–260.
5.
BasuJ., LudlowJ.W.Platform technologies for tubular organ regeneration. Trends Biotechnol, 28:526. 2010.
6.
KumarA., GodwinJ.W., GatesP.B., Garza-GarciaA.A., BrockesJ.P.Molecular basis for the nerve dependence of limb regeneration in an adult vertebrate. Science, 318:772. 2007.
7.
StappenbeckT.S., MiyoshiH.The role of stromal stem cells in tissue regeneration and wound repair. Science, 324:1666. 2009.
JayoM.J., JainD., WagnerB.J., BertramT.A.Early cellular and stromal responses in the regeneration of a functional mammalian bladder. J Urol, 180:392. 2008.
10.
KelleyR., WerdinE.S., BruceA.T., ChoudhuryS., WallaceS.M., IlaganR.M., CoxB.R., Tatsumi-FichtP., RiveraE.A., SpencerT., Scott RapoportH., WagnerB.J., GuthrieK., JayoM.J., BertramT.A., PresnellS.C.Tubular cell-enriched subpopulation of primary renal cells improves survival and augments kidney function in rodent model of chronic kidney disease. Am J Physiol Renal Physiol, 299:F1026. 2010.
11.
GoumansM.J., ZwijsenA., van RooijenM.A., HuylebroeckD., RoelenB.A., MummeryC.L.Transforming growth factor-beta signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice. Development, 126:3473. 1999.
12.
PooleT.J., FinkelsteinE.B., CoxC.M.The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev Dyn, 220:1. 2001.
13.
BuschmannI., HeilM., JostM., SchaperW.Influence of inflammatory cytokines on arteriogenesis. Microcirculation, 10:371. 2003.
14.
DresslerG.R.Advances in early kidney specification, development and patterning. Development, 136:3863. 2009.
15.
ChengH.T., KimM., ValeriusM.T., SurendranK., Schuster-GosslerK., GosslerA., McMahonA.P., KopanR.Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development, 134:801. 2007.
16.
MerkelC.E., KarnerC.M., CarrollT.J.Molecular regulation of kidney development: is the answer blowing in the Wnt?Pediatr Nephrol, 22:1825. 2007.
17.
KreidbergJ.A., SariolaH., LoringJ.M., MaedaM., PelletierJ., HousmanD., JaenischR.WT-1 is required for early kidney development. Cell, 74:679. 1993.
18.
CarrollT.J., ParkJ.S., HayashiS., MajumdarA., McMahonA.P.Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev Cell, 9:283. 2005.
19.
StarkK., VainioS., VassilevaG., McMahonA.P.Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature, 372:679. 1994.
20.
BadylakS.F.Regenerative medicine and developmental biology: the role of the extracellular matrix. Anat Rec B New Anat, 287:36. 2005.
JayoM.J., JainD., LudlowJ.W., PayneR., WagnerB.J., McLorieG., BertramT.A.Long-term durability, tissue regeneration and neo-organ growth during skeletal maturation with a neo-bladder augmentation construct. Regen Med, 3:671. 2008.
23.
BertramT.A., ChristG.J., AboushwarebT., WagnerB.J., JainD., LudlowJ.W., PayneR., JarapuY., TurnerC., JayoM.J.Total regenerated urinary bladders are structurally and pharmacologically similar to native canine bladder tissue. J Urol, 179:76. 2008.
24.
BertramT.A., ChristG.J., AnderssonK.E., AboushwarebT., FuellhaseC., SolexR., WagnerB.J., JainD., LudlowJ.W., PayneR., JayoM.J.Pharmacologic response of regenerated bladders in a preclinical model. FASEB J, 23:291. 2009.
25.
YooJ.J., OlsonJ., AtalaA., KimB.Regenerative medicine strategies for treating neurogenic bladder. In Neurol J, 15:109. 2011.
26.
BenarrochE.E.Neurol control of the bladder: recent advances and neurologic implications. Neurology, 75:1839. 2010.
27.
SextonC.C., NotteS.M., MaroulisC., DmochowskiR.R., CardozoL., SubramanianD., CoyneK.S.Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature. Int J Clin Pract, 65:567. 2011.
28.
CastellanM., GosalbezR., Perez-BrayfieldM., HealeyP., McDonaldR., LabbieA., LendvayT.Tumor in bladder reservoir after gastrocystoplasty. J Urol, 178:1771. 2007.
29.
WuX.R.Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer, 5:713. 2005.
30.
MadebR., GolijaninD., KnopfJ., MessingE.M.Current state of screening for bladder cancer. Expert Rev Anticancer Ther, 7:981. 2007.
DaneshmandS., BartschG.Improving selection of appropriate urinary diversion following radical cystectomy for bladder cancer. Expert Rev Anticancer Ther, 11:941. 2011.
33.
CrossW.R., EardleyI., LeeseH.J., SouthgateJ.A biomimetic tissue from cultured normal human urothelial cells: analysis of physiological function. Am J Physiol Renal Physiol, 289:F459. 2005.
34.
FraserM., ThomasD.F., PittE., HarndenP., TrejdosiewiczL.K., SouthgateJ.A surgical model of composite cystoplasty with cultured urothelial cells: a controlled study of gross outcome and urothelial phenotype. BJU Int, 93:609. 2004.
35.
ScrivenS.D., TrejdosiewiczL.K., ThomasD.F., SouthgateJ.Urothelial cell transplantation using biodegradable synthetic scaffolds. J Mater Sci Mater Med, 12:991. 2001.
36.
SouthgateJ., HuttonK.A., ThomasD.F., TrejdosiewiczL.K.Normal human urothelial cells in vitro: proliferation and induction of stratification. Lab Invest, 71:583. 1994.
37.
TurnerA., SubramanianR., ThomasD.F., HinleyJ., AbbasS.K., StahlschmidtJ., SouthgateJ.Transplantation of autologous differentiated urothelium in an experimental model of composite cystoplasty. Eur Urol, 59:447. 2011.
38.
TurnerA.M., SubramaniamR., ThomasD.F., SouthgateJ.Generation of a functional, differentiated porcine urothelial tissue in vitro. Eur Urol, 54:1423. 2008.
39.
OberpenningF., MengJ., YooJ.J., AtalaA.De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat Biotechnol, 17:149. 1999.
40.
De FilippoR.E., BertramT.A., JayoM.J., SeltzerE.Adaptive regulation of regenerated bladder size after implantation with Tengion Neo-Bladder Augment: Early clinical outcomes and preclinical evidence. J Urol, 181:267. 2009.
41.
SeltzerE., TillingerM., JayoM.J., BertramT.A.Role of biomechanical stimulation (cycling) in neo-bladder regeneration—translational basis for clinical outcomes. J Urol, 181:282. 2009.
42.
BertramT.A., ChristG.J., WagnerB.J., JainD., AboushwarebT., LudlowJ.W., PayneR., JarapuY., TurnerC., JayoM.J.Total urinary bladder regeneration with restoration of native structure and pharmacological response. FASEB J, 22:581. 2008.
43.
GenheimerC., GuthrieK., ShokesJ.E., BruceA.T., QuinlanS.F., SanghaN., IlaganR.M., BasuJ., BurnetteT., LudlowJ.W.Increased sensitivity for cancerous urothelial cell detection within a heterogeneous population of bladder smooth muscle cells using a two-step MACS/qRT-PCR approach. Appl Immunohistochem Mol Morphol, 19:184. 2011.
44.
BasuJ., GuthrieK., IlaganR., SanghaN., GenheimerC., QuinlanS., PayneR., RapoportS., KnightT., WagnerB.J., RiveraE., JayoM.J., JainD., BertramT.A., LudlowJ.W.Functional de novo Neo-Urinary Conduit from porcine peripheral blood and adipose-derived smooth muscle cells. Presented at the 7th Annual Meeting of the International Society for Stem Cell Research, Barcelona, Spain, 2009.
45.
OrlandoG., BaptistaP., BirchallM., De CoppiP., FarneyA., Guimaraes-SouzaN.K., OparaE., RogersJ., SeliktarD., Shapira-SchweitzerK., StrattaR.J., AtalaA., WoodK.J., SokerS.Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transplant Int, 24:223. 2011.
46.
LinF., MoranA., IgarashiP.Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest, 115:1756. 2005.
47.
HumphreysB.D., ValeriusM.T., KobayashiA., MugfordJ.W., SoeungS., DuffieldJ.S., McMahonA.P., BonventreJ.V.Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell, 2:284. 2008.
LittleM.H., BertramJ.F.Is there such a thing as a renal stem cell?J Am Soc Nephrol, 20:2112. 2009.
50.
LittleM.H., RaeF.K.Review article: Potential cellular therapies for renal disease: can we translate results from animal studies to the human condition?Nephrology (Carlton), 14:544. 2009.
